These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15824093)

  • 1. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    Krishnan S; Manavathu EK; Chandrasekar PH
    J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
    Chryssanthou E; Loebig A; Sjölin J
    J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
    Chryssanthou E; Sjölin J
    J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
    Kiraz N; Oz Y; Dag I
    Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    Espinel-Ingroff A; Johnson E; Hockey H; Troke P
    J Antimicrob Chemother; 2008 Mar; 61(3):616-20. PubMed ID: 18222957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
    J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
    Manavathu EK; Abraham OC; Chandrasekar PH
    Clin Microbiol Infect; 2001 Mar; 7(3):130-7. PubMed ID: 11318811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Wetter TJ; Hazen KC; Cutler JE
    Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
    van de Sande WW; Tavakol M; van Vianen W; Bakker-Woudenberg IA
    Med Mycol; 2010 Feb; 48(1):48-55. PubMed ID: 20055743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
    Lass-Flörl C; Nagl M; Speth C; Ulmer H; Dierich MP; Würzner R
    Antimicrob Agents Chemother; 2001 Jan; 45(1):124-8. PubMed ID: 11120954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
    Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.